#COVID19 #VariantDashboard - #UnitedStates

TOP lineages (#15DAYTRENDS):

54.5% XBB.1.5
5.8% XBB.1.16
5.2% XBB.1.9.1
2.6% XBB.1.16.1
2.5% XBB.1.5.1
2.2% XBB.2.3
2.1% XBB.1.9.2
1.7% EG.1

#SARSCoV2 Tracker: http://tinyurl.com/mryj4uu7 Updated: 05/04/23

1/n

#COVID19 #VariantDashboard - #USA
[without "Airport Surveillance" sequences]

Top lineages (#15DayTrends):

XBB.1.5 (62.5%)
XBB.1.16 (3.4%)
XBB.1.9.1 (3.4%)
XBB.1.5.1 (2.6%)
XBB.1.5.13 (1.6%)
XBB.2.3 (1.5%)
FL.2 (1.3%)
EG.1 (1.1%)
FU.1 (1.1%)
XBB.1.16.1 (1.1%)

2/n

Airport sequences constitute ~19.5% of sequences with sample collection dates in the last 15 days (#15DayTrends)

Its going to be a three way race to outcompete XBB.1.5*: XBB.1.9* vs XBB.1.16* vs XBB.2.3*

As of now, XBB.1.16* family looks to over take everything else!

3/n

Sequence count by US States

#Texas has submitted a big share of sequences with specimen collection dates on or after 04/19/2023

XBB.1.5 is still at the top spot; followed by XBB.1.9.1 and XBB.1.16

4/n

.@CDCgov updated variant proportions estimates on 04/28/2023 (updated every Friday)

XBB.2.3* might make an entry tomorrow!
Prudent to start tracking EG.1*, XBB.1.16.1 as well
https://twitter.com/RajlabN/status/1651967457064628228

5/n
---
RT @RajlabN
SARSCoV2 #VariantProportions - #USA |04/28/23

New @CDCgov #Nowcast estimates:

Top circulating lineages:

XBB.1.5 (68.8%) ⬇️
XBB.1.16 (11.7%) ⬆️
XBB.1.9.1 (9%)
XBB.1.9.2 (3.7…
https://twitter.com/RajlabN/status/1651967457064628228

Raj Rajnarayanan on Twitter

“SARSCoV2 #VariantProportions - #USA |04/28/23 New @CDCgov #Nowcast estimates: Top circulating lineages: XBB.1.5 (68.8%) ⬇️ XBB.1.16 (11.7%) ⬆️ XBB.1.9.1 (9%) XBB.1.9.2 (3.7%) XBB (2.4%) XBB.1.5.1 (2.2%) FD.2. (1.3%) https://t.co/Qq4vwqXtij… 1/n”

Twitter

XBB.1.16 has the potential to outcompete all other circulating lineages.

Everyone is closely watching XBB.1.16 hotspots for clues

Tracker: https://public.tableau.com/app/profile/raj.rajnarayanan/viz/TrackingXBB_1_16LineageOverTime/XBB_1_16

6/n

XBB.1.16 is one of the fittest variant in circulation right now.. and is picking up additional mutations... "its the one to watch"

H/T @ErinMPrater @WellatFortune
@FortuneMagazine
https://fortune.com/well/2023/03/31/arcturus-covid-variant-watch-who-world-health-organization-xbb116-omicron-wave

7/n

‘Everyone is kind of tired and has given up’ on COVID. But this new variant is ‘one to watch,’ the WHO says

Here’s what we know so far about the latest variant to raise eyebrows—and the first to do so in several months.

Fortune

Predicted Immune Escape and ACE2 binding of top lineages in USA (relative to BA.2)

Bivalent boosters (OG/Omicron.BA.5) will potentially protect the boosted from getting severe disease/ hospitalizations.

Get updated if you haven't already!
https://public.tableau.com/app/profile/raj.rajnarayanan/viz/ImmuneEscapevsACE2BindingrelativetoBA2-USA15DayTrends/Dashboard2

8/n

.@CDCgov has authorized a second dose of the bivalent Omicron-BA.5 vaccine for older adults and immunocompromised adults
https://twitter.com/RajlabN/status/1648819491378192384

9/n
---
RT @RajlabN
.@CDCgov allows older adults and immunocompromised adults to get second dose of the bivalent Omicron-BA.5 vaccine https://twitter.com/CDCgov/status/1648798530767560707
https://twitter.com/RajlabN/status/1648819491378192384

Raj Rajnarayanan on Twitter

“.@CDCgov allows older adults and immunocompromised adults to get second dose of the bivalent Omicron-BA.5 vaccine”

Twitter

#COVID19 #Hospitalizations in the #UnitedStates

>60 yr old & immunocompromised Have a good look at @CDCgov info on #Boosters!

#Ventilate Indoor spaces

Sick? --> Wear a good quality #Mask!

Hospital Tracker (by States, by age group):https://public.tableau.com/app/profile/raj.rajnarayanan/viz/COVID19HospitalizationsUSA/COVID19_HOSP_USA

11/n

Status of the latest #COVID19 Wave in #NewYork #Bellwether #State

XBB.1.5 is still the top circulating lineages in NY

[includes airport surveillance seqs]

12/n

Status of the latest #COVID19 Wave in #California

XBB.1.5 is still the top circulating lineage in CA (#15DayTrends) includes airport surveillance sequences

13/n

Status of the latest #COVID19 Wave in #Texas

XBB.1.5 is still the top circulating lineage in TX (#15DayTrends)

14/n

USA Airport surveillance update #15DayTrends

149 sequences from 6 US States (#California, #NewYork, #Washington, #NewJersey, #Georgia and #Virginia) from @CDCgov's Traveler-Based Genomic Surveillance Program.

*Includes pooled swabs & Many bad QC seqs

15/n

As COVID Tracking Wanes, Are We Letting Our Guard Down Too Soon? "Closing up shop too early could mean we are blindsided" “You have to maintain a base level of sequencing for new variants"

H/T @DohenyKathleen @WebMD
https://webmd.com/covid/news/20230411/are-we-letting-our-guard-down-on-covid-too-quickly

16/n

As COVID Tracking Wanes, Are We Letting Our Guard Down Too Soon?

As data tracking declines and mandates disappear, some experts say it’s time to move on, but others are worried about the ability to gear up for the next variant, calling for better surveillance.

WebMD

The next pandemic could be ‘as infectious as this one but far more lethal’—and make COVID look like a cakewalk, expert warns

H/T @ErinMPrater @WellatFortune
@FortuneMagazine
https://fortune.com/well/2023/04/26/next-pandemic-sars-cov-3-infectious-transmissibility-lethality-covid-mers-bird-flu/

17/n

The next pandemic could be ‘as infectious as this one but far more lethal’—and make COVID look like a cakewalk, expert warns

“There’s nothing in the book of life that says you couldn’t have a virus that’s as infectious as this one but far more lethal,” he noted.

Fortune

"We don't have to feel pressured to move on from a real public health threat. We have a collective responsibility to protect our seniors and immunocompromised. Letting the virus spread unchecked is never a viable option."

H/T @filth_filler
https://salon.com/2023/05/02/as-mutates-the-vaccine-goalpost-has-shifted-to-preventing-severe-illness-and/

18/n

The FDA now allows some people to get a second bivalent COVID vaccine. Will anyone get it?

A report on the FDA's new policy on bivalent boosters, and why they don't work as well as they used to

Salon.com